← Back to patent-cliff list
CAS 500782-67-2
benzyl (S)-2-benzyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate
Codes: GGTI-2418-001
Application context (from source-drug indications)
Cutaneous T-cell lymphomaCamprenstatPeripheral T-cell lymphomaCamprenstat
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Camprenstat | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
benzyl (S)-2-benzyl-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate→4-(chloromethyl)-5-methyl-1-trityl-1H-imidazole→benzyl (S)-2-benzyl-4-((4-methyl-1-trityl-1H-imidazol-5-yl)methyl)-3-oxo-3,4-dihydropyrazine-1(2H)-carboxylate→(S)-3-benzyl-1-((4-methyl-1-trityl-1H-imidazol-5-yl)methyl)piperazin-2-one→(S)-methyl 2-amino-4-methylpentanoate hydrochloride→methyl ((S)-2-benzyl-4-((4-methyl-1-trityl-1H-imidazol-5-yl)methyl)-3-oxopiperazine-1-carbonyl)-L-leucinate→methyl ((S)-2-benzyl-4-((4-methyl-1H-imidazol-5-yl)methyl)-3-oxopiperazine-1-carbonyl)-L-leucinate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.